FindTrial
Sign In

18F-FDG-PET/CT radiomic features in Hodgkin lymphoma are predictive of outcome

18F-FDG-PET/CT radiomic features in Hodgkin lymphoma are predictive of outcome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045957
Enrollment
Unknown
Registered
2021-04-30
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hodgkin lymphoma

Interventions

Gold Standard:Pathological diagnosis
Index test:18F-FDG PET-CT

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 72 Years

Inclusion criteria

Inclusion criteria: 1. Patients with Hodgkin's lymphoma confirmed by pathology; 2. 18F-FDG PET/CT without any lymphoma related treatment before imaging.

Exclusion criteria

Exclusion criteria: 1. Previously known history of other malignant diseases; 2. Incomplete imaging data.

Design outcomes

Primary

MeasureTime frame
Progression-free survival;—

Countries

China

Contacts

Public ContactDeng Shengming

The First Affiliated Hospital of Soochow University

dshming@163.com+86 15051510189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026